Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for POCD in Supratentorial Craniotomy
NCT00975910Phase 2Completed
- Sponsor
- Capital Medical University
- Start
- Sep 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in Post-operative cognitive dysfunction (POCD), sponsored by Capital Medical University. Started Sep 2009; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT00975910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975910.